Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Czechia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20071
20081
20101
20112
20132
20141
20182
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Motol3
AstraZeneca2
Amgen1
Bayer1
Boston Scientific Corporation1
CSL Behring1
Charles University, Czech Republic1
Cogentus Pharmaceuticals1
Eli Lilly and Company1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease15
Myocardial Infarction5
Stroke4
Acute Coronary Syndrome3
Cardiovascular Diseases3
Heart Diseases3
Peripheral Arterial Disease3
Angina Pectoris2
Atherosclerosis2
Cerebrovascular Disorders2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.